Senftleber, Ninna Karsbæk http://orcid.org/0000-0001-6619-1549
Andersen, Mette K. http://orcid.org/0000-0001-8227-1469
Jørsboe, Emil http://orcid.org/0000-0002-0593-7906
Stæger, Frederik Filip http://orcid.org/0000-0002-2295-8637
Nøhr, Anne Krogh
Garcia-Erill, Genis http://orcid.org/0000-0003-3150-1708
Meisner, Jonas
Santander, Cindy G. http://orcid.org/0000-0003-3021-6809
Balboa, Renzo F. http://orcid.org/0000-0003-2821-8020
Gilly, Arthur
Bjerregaard, Peter
Larsen, Christina Viskum Lytken
Grarup, Niels http://orcid.org/0000-0001-5526-1070
Jørgensen, Marit Eika
Zeggini, Eleftheria http://orcid.org/0000-0003-4238-659X
Moltke, Ida http://orcid.org/0000-0001-7052-8554
Hansen, Torben http://orcid.org/0000-0001-8748-3831
Albrechtsen, Anders http://orcid.org/0000-0001-7306-031X
Funding for this research was provided by:
Novo Nordisk Fonden (NNF17OC0028136, NNF17SH0027192, NNF20OC0061343, NNF20OC0061343, NNF16OC0019986, NNF18CC0034900, NNF20OC0061343)
Det Frie Forskningsråd (DFF-0135-00211B)
Karen Elise Jensens Fond
Department of Health, Greenland
Københavns Universitet
AstraZeneca
Amgen
Boehringer Ingelheim
Novo Nordisk
Sanofi Aventis
Villum Fonden (19114)
Article History
Received: 27 February 2023
Revised: 14 September 2023
Accepted: 11 October 2023
First Online: 30 October 2023
Competing interests
: The authors declare no competing interests.
: The study was approved by the Commission for Scientific Research in Greenland (project 2011–13, ref. no. 2011–056978; project 2013–13, ref.no. 2013–090702; and project 2012-16/17, ref.no. 2017-12997) and was conducted in accordance with the ethical standards of the Declaration of Helsinki, second revision. All participants gave informed consent.